Point of Care Diagnostics Market
Point of Care Diagnostics Market - Global Industry Assessment & Forecast
Segments Covered
- By Product Glucose Testing, Hb1Ac Testing, Coagulation Testing, Fertility/Pregnancy, Infectious Disease, Cardiac Markers, Thyroid Stimulating Hormone, Hematology, Primary Care Systems, Decentralized Clinical Chemistry, Feces, Lipid Testing, Cancer Marker, Blood Gas/Electrolytes, Ambulatory Chemistry, Drug of Abuse (DOA) Testing, Urinalysis/Nephrology
- By End Users Clinics, Hospitals, Home, Assisted Living Healthcare Facilities, Laboratories
- By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base Year: | 2022 |
Forecast Years: | 2023 - 2030 |
Historical Years: | 2017 - 2021 |
Revenue 2022: | USD 45.06 Billion |
Revenue 2030: | USD 95.89 Billion |
Revenue CAGR (2023 - 2030): | 9.90% |
Fastest Growing Region (2023 - 2030) | Asia Pacific |
Largest Region (2022): | North America |
Customization Offered
- Cross-segment Market Size and Analysis for Mentioned Segments
- Additional Company Profiles (Upto 5 With No Cost)
- Additional Countries (Apart From Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request Customization Speak To Analyst
Research Methodology: Point of Care Diagnostics Market by Product by End Users by Region - Global Market Assessment, 2021 - 2028
Secondary Research
Primary Research:
The later stage covers data validation and collection from primary research. The information gained/procured from the secondary data sources is validated through extensive primary interviews with industry experts across the Point of Care Diagnostics supply chain. The primary research is also conducted to identify key players in the market and to gather and validate already procured information pertaining to their market-specific financial information. Moreover, primary research is used to gain/validate information about:
- Point of Care Diagnostics market size at regional and country level
- Key industry players and their market share and Point of Care Diagnostics market-specific sales/revenue
- Understanding of the Point of Care Diagnostics supply chain and overall ecosystem
Data Triangulation and Market Size Estimations
After arriving at the global market numbers, top-down and bottom-up approaches are used to estimate, validate and finalize the market size of the Point of Care Diagnostics market. After the determination of the overall market size, the market is divided into various segments and sub-segments. Moreover, these same approaches mentioned above were used to derive and estimate market numbers for mentioned segments/sub-segments in the market. During the data triangulation process, the data was analyzed by employing various data models and statistical techniques to arrive at exact statistics and market size for each segment/sub-segment of the market. The data is analyzed and triangulated by considering all the key market impacting factors from both supply and demand side of Point of Care Diagnostics market.
FAQ
Frequently Asked Question
What is the global demand for Point of Care Diagnostics in terms of revenue?
-
The global Point of Care Diagnostics valued at USD 45.06 Billion in 2022 and is expected to reach USD 95.89 Billion in 2030 growing at a CAGR of 9.90%.
Which are the prominent players in the market?
-
The prominent players in the market are F. Hoffmann-La Roche Ltd., Qiagen, Danaher Corp., Becton Dickinson (BD), Biomerieux SA, Abbott Laboratories, Siemens Healthcare AG, Zoetis Inc., Instrumentation Laboratory, Nova Biomedical, Trividia Health Inc., Quidel Corp., Trinity Biotech, Sekisui Diagnostics, Orasure Technologies Inc., Nipro Corp., Spectral Medical Inc..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 9.90% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Point of Care Diagnostics include
- High prevalence of infectious diseases
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Point of Care Diagnostics in 2022.